Search results for: 'responsive materials'

13 Oct 2020  |  North America  |  Market Research

Increasing Adoption of Low-cost Devices with Simple Designs in Response to COVID-19 to Disrupt the US & EU-5 Ventilator Market, 2025

Rising Preference for Home-based Care, Aided by Remote Monitoring Technologies, to Drive New Growth Opportunities

Infographics

×

Revenue for the US & EU-5 ventilators market is expected to increase by 370.7% in 2020 driven by the ongoing Coronavirus 2019 (COVID-19) situation. The home care segment is expected to see a comparatively strong growth potential post-pandemic. This study assesses the revenue growth impact on different ventilator market segments. It also analyzes fu...

31 May 2022  |  North America  |  Market Research

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...

10 Jun 2015  |  North America  |  Market Research

Analysis of the US Advanced Wound Care Technologies Market

Emerging Technologies Expand Wound Applications

Infographics

×

Cost pressures from cuts in reimbursement, the PPACA imposed excise tax, and rising cost of materials are straining profitability for many wound care companies that develop products for established market segments. This research service examines the US advanced wound care technologies market to illustrate the challenges faced by market participants...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

Research shows that environmental surfaces in healthcare settings play a crucial role in pathogen transmission, leading to healthcare-acquired infections (HAIs), which have a considerable cost burden. Outpatient settings also pose significant infection risks. In the United States, millions of patients frequent outpatient facilities such as ambulato...

07 Jul 2021  |  North America  |  Market Research

United States Healthcare Consumerism Growth Opportunities

The Quantified Self Consumer Behavior and Innovative Business Models Create Future Growth Potential

Infographics

×

This research service examines the future of healthcare consumerism in the United States in terms of changing patient demographics and demands, technological advancements, digital health, shift in consumer behavior to non-traditional healthcare settings, and innovative healthcare business models. Healthcare consumerism is on the rise as individual...

This Frost & Sullivan study focuses on sustainability in the MedTech industry and offers a detailed discussion on 2 sustainability programs, Climate Action and Responsible Consumption and Production. The study's focus areas include key regulations in the EU, such as the EUDAMED database and green taxonomy and ESG in the United States and Asia-Pacif...

The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research. With digitalization, it is now easy and efficient to use analytics and connectivity solutions to analyze this data and draw insights for better care de...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...